MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Amcal Ibuprofen Plus Codeine | |
New | Am-o-lin Baby Cream | |
New | Bepanthen Tattoo Ointment | |
New | Berocca Sport | |
New | Bortezomib Ever Pharma | |
New | Canesten Clotrimazole Athlete's Foot Cream | |
New | Cipla Isoprenaline | |
New | Co-Trimoxazole Paediatric Suspension (Aspen) | |
New | Elevit DHA | |
New | Equazen Capsules | |
New | Equazen Chews | |
New | Equazen Forte | |
New | Eurofolic (Germany) | |
New | Femular Forte | |
New | Gincosan | |
New | Ginsana | |
New | Ixiaro | |
New | KamRAB | |
New | Ledaga | |
New | Legalon | |
New | Mebrofenin | |
New | MenQuadfi | |
New | NanoScan | |
New | Nardil Phenelzine Sulfate Tablets USP, 15 mg (Canada) | |
New | Nextstellis | |
New | Nopil | |
New | Noumed Valaciclovir | |
New | Omegapharm Thiopental Sodium | |
New | ReDormin Forte | |
New | Redoxon Immunity | |
New | Renocis | |
New | Ruzurgi | |
New | Sodium Nitroprusside Medsurge | |
New | Sultiam-neuraxpharm | |
New | Systane Complete Preservative-Free | |
New | Systane Ultra Preservative-Free | |
New | Topreloc-XL | |
New | Xospata | |
Reinstated | Antabuse | |
Reinstated | Co-Trimoxazole Infusion | |
Reinstated | Ethambutol Tablets (Morningside Healthcare) | |
Revised | Adempas | Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Precautions for Storage |
Revised | Air Liquide Australia Limited Nitronox | TGA Date |
Revised | Air Liquide Australia Limited Nitrous Oxide | Sponsor, TGA Date |
Revised | Akynzeo | Sponsor |
Revised | Alepam | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Aloxi | Sponsor |
Revised | Alunbrig | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Amgevita | Nature and Contents of Container |
Revised | APO-Aripiprazole | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | APO-Escitalopram | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Ezetimibe | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor, Therapeutic Indications |
Revised | APO-Mebeverine | TGA Date |
Revised | APO-Meloxicam Capsules | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APO-Meloxicam Tablets | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | APO-Nicorandil | TGA Date |
Revised | APX-Clopidogrel/Aspirin 75/100 | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container |
Revised | APX-Lamotrigine | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmaceutical Form, Special Warnings and Precautions for Use |
Revised | Aspen Methadone Syrup | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Escitalopram | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Blooms the Chemist Ezetimibe | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Sponsor, Therapeutic Indications |
Revised | Braltus | List of Excipients |
Revised | Brilinta | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Bupivacaine Spinal Heavy BNM | Special Warnings and Precautions for Use |
Revised | Canesoral | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Canesten Clotrimazole Thrush Treatment | Precautions |
Revised | Canesten Clotrimazole Thrush Treatment Once Pessary + Cream | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Canesten Extra Clotrimazole and Hydrocortisone Cream | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Cefazolin-AFT | Qualitative and Quantitative Composition |
Revised | Celaxib | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Cervidil | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Shelf Life, Special Warnings and Precautions for Use |
Revised | Cilicaine Syringe 1.5 | Nature and Contents of Container |
Revised | Clopidogrel Lupin | TGA Date |
Revised | Clopidogrel Winthrop Plus Aspirin | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container |
Revised | Clozitor | Nature and Contents of Container |
Revised | CoPlavix | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Cosentyx | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cosopt | TGA Date |
Revised | Cosopt Preservative Free | TGA Date |
Revised | Cyklokapron | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Cystagon | List of Excipients, Nature and Contents of Container |
Revised | Dasatinib ARX | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | DBL Amikacin Injection | Pharmaceutical Form |
Revised | Diabex XR 500 | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Domion | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, New indication, Pharmacological Properties, Shelf Life, Special Warnings and Precautions for Use |
Revised | Dukoral | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Duocover | Interactions with Other Medicines and Other Forms of Interactions |
Revised | DuoPlidogrel | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Dupixent | Adverse Effects (Undesirable Effects), Deleted Presentation, Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Elaxine SR | TGA Date |
Revised | Erlyand | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Escitalopram Sandoz | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Esmeron | Adverse Effects (Undesirable Effects) |
Revised | Eylea | Dose and Method of Administration, Pharmacological Properties |
Revised | Ezemichol | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Ezetimibe/Simvastatin Sandoz | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ferrosig Injection | Adverse Effects (Undesirable Effects) |
Revised | Forteo | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Fulvestrant Accord | Pharmacological Properties, Therapeutic Indications |
Revised | Fulvestrant Sandoz | TGA Date |
Revised | Fycompa | Pharmacological Properties |
Revised | Glycophos | TGA Date |
Revised | Hemlibra | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Hydroxychloroquine GH | Fertility, Pregnancy and Lactation, Nature and Contents of Container, Pharmacological Properties |
Revised | Iberogast | TGA Date |
Revised | Ikotab | Nature and Contents of Container |
Revised | Imatinib RBX | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Imbruvica | Special Warnings and Precautions for Use |
Revised | Inflamax Liquid Caps 25 | TGA Date |
Revised | Influvac Tetra | Special Warnings and Precautions for Use |
Revised | Janumet | Pharmacological Properties |
Revised | Janumet XR | Pharmacological Properties |
Revised | Jardiance | Adverse Effects (Undesirable Effects) |
Revised | Kalixocin | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Keytruda | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Kisqali | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Kivexa | Dose and Method of Administration, Pharmacological Properties |
Revised | Kymriah | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Lamitan | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Lamotrigine GH | Adverse Effects (Undesirable Effects), Boxed Warnings, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Largactil | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Leflunomide APOTEX | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Lemtrada | Adverse Effects (Undesirable Effects) |
Revised | Lexam | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Litak | Nature and Contents of Container, Qualitative and Quantitative Composition |
Revised | Lubri-Gel Lubricating Gel | Presentation |
Revised | Metrol-XL | TGA Date |
Revised | Micardis Plus | Adverse Effects (Undesirable Effects) |
Revised | Moxifloxacin APO | TGA Date |
Revised | Nasonex Allergy Aqueous Nasal Spray | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Neulactil | Adverse Effects (Undesirable Effects), Contraindications, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Nizac | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Noradrenaline Juno | Contraindications |
Revised | NuvaRing | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Nuvaxovid | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Ondansetron-AFT | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Orion Phenobarbital Elixir | Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Orudis SR Capsules and Suppositories | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Oruvail SR | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Ospolot | Nature and Contents of Container |
Revised | Otodex | Special Warnings and Precautions for Use |
Revised | Oxycodone Juno | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Oxycodone Viatris | Product Name change |
Revised | Petrus Glycerol Suppositories BP | Product Name change |
Revised | Pfizer (Australia) Bupivacaine Hydrochloride Injection BP | List of Excipients, Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Pharmacor Mycophenolate 250 | Special Warnings and Precautions for Use |
Revised | Pharmacor Posaconazole | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pharmacor Quetiapine | Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Phenoxymethylpenicillin-AFT | Shelf Life |
Revised | Physeptone | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Piperacillin/Tazobactam Kabi | Special Warnings and Precautions for Use |
Revised | Placil | Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, Physicochemical Properties |
Revised | Polaramine | Contraindications, Precautions |
Revised | Pro-Banthine | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Proctosedyl Ointment | Pharmaceutical Form, Physicochemical Properties |
Revised | Proctosedyl Suppositories | Pharmaceutical Form, Physicochemical Properties |
Revised | Prolastin C Liquid | Name of Medicine, Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Qinlock | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Quadracel | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Name of Medicine, Nature and Contents of Container, Pharmacological Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Rekovelle | Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties |
Revised | Remotiv | TGA Date |
Revised | Rimycin | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Rinvoq | Special Warnings and Precautions for Use |
Revised | Saflutan | TGA Date |
Revised | Sandoz Lamotrigine | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Sofradex | Special Warnings and Precautions for Use |
Revised | Stelara | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Nature and Contents of Container, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Tecentriq | Adverse Effects (Undesirable Effects) |
Revised | Teicoplanin Sandoz | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use |
Revised | Tenormin | Qualitative and Quantitative Composition, Sponsor |
Revised | Teriflagio | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Terrosa | Nature and Contents of Container |
Revised | Teveten Plus | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Tinasil | Nature and Contents of Container |
Revised | Topamax | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Trimbow | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, New indication, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Tygacil | Fertility, Pregnancy and Lactation |
Revised | Tykerb | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Valdoxan | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Valium | Pharmaceutical Form |
Revised | Verzenio | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications |
Revised | Vimpat | Fertility, Pregnancy and Lactation |
Revised | Vimpat Injection | Fertility, Pregnancy and Lactation |
Revised | Votrient | Special Warnings and Precautions for Use |
Revised | Xalacom | Adverse Effects (Undesirable Effects) |
Revised | Xalamol 50/5 | Nature and Contents of Container |
Revised | Xalaprost | Nature and Contents of Container |
Revised | Xevudy | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Zavesca | Fertility, Pregnancy and Lactation |
Revised | Zofran | Adverse Effects (Undesirable Effects), Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Zoloft | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Zydol SR | TGA Date |
Deleted | Cecenu Lomustine (Medac) | |
Deleted | Dimirel | |
Deleted | Fibre Health Natural Granular | |
Deleted | Forthane | |
Deleted | HairScience for Dandruff Shampoo | |
Deleted | Nitrofurantoin 100 mg Capsules (Morningside Healthcare) | |
Deleted | Novalac Diarrhoea Infant Formula | |
Deleted | Olmertan (old formulation) | |
Deleted | Vinorelbine Injection USP (Sagent) |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au